| Rank |
Title |
Journal |
Year |
PubWeight™‹?› |
|
1
|
Uptake of risk-reducing surgery in unaffected women at high risk of breast and ovarian cancer is risk, age, and time dependent.
|
Cancer Epidemiol Biomarkers Prev
|
2009
|
1.36
|
|
2
|
ERCC1 mRNA expression is not associated with response and survival after platinum-based chemotherapy regimens in advanced non-small cell lung cancer.
|
J Thorac Oncol
|
2007
|
1.29
|
|
3
|
Comprehensive CYP2D6 genotype and adherence affect outcome in breast cancer patients treated with tamoxifen monotherapy.
|
Breast Cancer Res Treat
|
2010
|
1.18
|
|
4
|
Xeroderma pigmentosum group D haplotype predicts for response, survival, and toxicity after platinum-based chemotherapy in advanced nonsmall cell lung cancer.
|
Cancer
|
2006
|
1.02
|
|
5
|
Glutathione-S-transferase P1 isoenzyme polymorphisms, platinum-based chemotherapy, and non-small cell lung cancer.
|
J Thorac Oncol
|
2006
|
1.00
|
|
6
|
Coexpression of parathyroid hormone related protein and its receptor in early breast cancer predicts poor patient survival.
|
Clin Cancer Res
|
2002
|
0.98
|
|
7
|
Acute chemotherapy-related toxicity is not increased in BRCA1 and BRCA2 mutation carriers treated for breast cancer in the United Kingdom.
|
Clin Cancer Res
|
2006
|
0.94
|
|
8
|
Omitting elective nodal irradiation during thoracic irradiation in limited-stage small cell lung cancer--evidence from a phase II trial.
|
Lung Cancer
|
2011
|
0.88
|
|
9
|
Late toxicity is not increased in BRCA1/BRCA2 mutation carriers undergoing breast radiotherapy in the United Kingdom.
|
Clin Cancer Res
|
2006
|
0.86
|
|
10
|
Use of G-CSF during concurrent chemotherapy and thoracic radiotherapy in patients with limited-stage small-cell lung cancer safety data from a phase II trial.
|
Lung Cancer
|
2011
|
0.85
|
|
11
|
Extrapulmonary small cell carcinoma: a clinicopathological study with identification of potential diagnostic mimics.
|
Histopathology
|
2012
|
0.82
|
|
12
|
Phase III trial of gemcitabine and carboplatin versus mitomycin, ifosfamide, and cisplatin or mitomycin, vinblastine, and cisplatin in patients with advanced nonsmall cell lung carcinoma.
|
Cancer
|
2003
|
0.81
|
|
13
|
Adult weight gain and central obesity in women with and without a family history of breast cancer: a case control study.
|
Fam Cancer
|
2007
|
0.80
|
|
14
|
Dose intensified hypofractionated intensity-modulated radiotherapy with synchronous cetuximab for intermediate stage head and neck squamous cell carcinoma.
|
Acta Oncol
|
2014
|
0.78
|
|
15
|
Comparison of multi-frequency bioimpedance with perometry for the early detection and intervention of lymphoedema after axillary node clearance for breast cancer.
|
Breast Cancer Res Treat
|
2015
|
0.78
|
|
16
|
Randomised phase II trial of 4 dose levels of single agent docetaxel in performance status (PS) 2 patients with advanced non-small cell lung cancer (NSCLC): DOC PS2 trial. Manchester lung cancer group.
|
Lung Cancer
|
2011
|
0.75
|